Search Result "PI3K-Akt network"
Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Journal: Current Signal Transduction Therapy
Volume: 3 Issue: 2 Year: 2008 Page: 138-151
Author(s): Masayuki Noguchi, Toshiyuki Obata, Futoshi Suizu
PI3K-Akt Signaling and Viral Infection
Journal: Recent Patents on Biotechnology
Volume: 2 Issue: 3 Year: 2008 Page: 218-226
Author(s): Wen-Tsai Ji, Hung J. Liu
Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 9 Year: 2009 Page: 1024-1038
Author(s): Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka, Osamu Yamada
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 187-198
Author(s): Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link, Juan F.M. Leal
Synthesis and Biological Activity of Akt/PI3K Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 1127-1136
Author(s): C. Redaelli, F. Granucci, L. De Gioia, L. Cipolla
Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 24 Issue: 16 Year: 2024 Page: 1496-1520
Author(s):
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 29-57
Author(s): Sandra E. Ghayad, Pascale A. Cohen
Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 5 Issue: 6 Year: 2005 Page: 575-589
Author(s): Y. L. Chen, P.- Y. Law, H. H. Loh
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 11 Year: 2020
Author(s): Carolina Simioni,Giorgio Zauli,Daniela Milani,Luca M. Neri
Doi: 10.2174/9789811422133120110003
Chidamide Inhibits Cell Proliferation via the PI3K/AKT Pathway in K562 Cells Based on Network Pharmacology and Experimental Validation
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 26 Year: 2021 Page: 2990-2998
Author(s): Simin Liang,Xiaojia Zhou,Duo Cai,Fernando Rodrigues-Lima,Li Wang